Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Dogwood Therapeutics Inc (DWTX)

Dogwood Therapeutics Inc (DWTX)
5.36 x 10 5.46 x 45
Post-market by (Cboe BZX)
5.46 +0.09 (+1.68%) 04/22/25 [NASDAQ]
5.36 x 10 5.46 x 45
Post-market 5.36 -0.10 (-1.83%) 19:59 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
4.54
Day High
5.75
Open 5.17
Previous Close 5.37 5.37
Volume 728,800 728,800
Avg Vol 2,340,955 2,340,955
Stochastic %K 52.44% 52.44%
Weighted Alpha -85.09 -85.09
5-Day Change +2.46 (+82.00%) +2.46 (+82.00%)
52-Week Range 1.62 - 29.28 1.62 - 29.28
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 10,263
  • Shares Outstanding, K 1,911
  • Annual Sales, $ 0 K
  • Annual Income, $ -12,350 K
  • EBIT $ -12 M
  • EBITDA $ -12 M
  • 60-Month Beta 1.99
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.05
  • Number of Estimates 1
  • High Estimate -1.05
  • Low Estimate -1.05
  • Prior Year -1.75
  • Growth Rate Est. (year over year) +40.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.76 +97.78%
on 04/14/25
Period Open: 6.33
7.73 -29.37%
on 04/21/25
-0.87 (-13.74%)
since 03/21/25
3-Month
2.72 +100.74%
on 01/23/25
Period Open: 2.80
29.28 -81.35%
on 01/23/25
+2.66 (+95.00%)
since 01/22/25
52-Week
1.62 +237.04%
on 11/18/24
Period Open: 10.64
29.28 -81.35%
on 01/23/25
-5.18 (-48.70%)
since 04/22/24

Most Recent Stories

More News
Dogwood Therapeutics, Inc. Receives Nasdaq Confirmation of Compliance

DWTX : 5.46 (+1.68%)
Dogwood Therapeutics, Inc. Regains Nasdaq Compliance

DWTX : 5.46 (+1.68%)
Dogwood Therapeutics Announces Fourth Quarter and Full Year 2024 Financial Results

DWTX : 5.46 (+1.68%)
Dogwood Therapeutics Announces Dosing of First Patient in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy-Induced Neuropathic Pain

DWTX : 5.46 (+1.68%)
Dogwood Therapeutics, Inc. Announces Pricing of $4.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

DWTX : 5.46 (+1.68%)
Dogwood Therapeutics, Inc. Announces Conversion of Existing $19.5M in Debt to Equity, Strengthening Balance Sheet Moving Forward

DWTX : 5.46 (+1.68%)
Dogwood Therapeutics Becomes Most Actively Discussed Biotech Stock Among Retail Traders After Stunning 370% Surge

The company’s focus on pain and fatigue-related disorders has generated excitement, bolstered by its non-opioid analgesic and antiviral platforms.

DWTX : 5.46 (+1.68%)
Dogwood Therapeutics Announces Patient Dosing in Phase 2b Trial Evaluating Halneuron® in Patients with Chemotherapy Induced Neuropathy (CINP) to Commence First Quarter of 2025

DWTX : 5.46 (+1.68%)
Dogwood Therapeutics Reports Positive Results from IMC-2 Study on Long-COVID Related Fatigue and Sleep Disturbance

IMC-2 treatment shows significant reductions in Long-COVID fatigue and sleep issues compared to placebo, informing future Phase 2 study design.Quiver AI SummaryDogwood Therapeutics, Inc. announced promising...

DWTX : 5.46 (+1.68%)
Dogwood Therapeutics, Inc. Announces Low Dose IMC-2 Treatment Reduces Long-COVID Related Fatigue and Sleep Disturbance in an Investigator-Initiated Study

DWTX : 5.46 (+1.68%)

Business Summary

Dogwood Therapeutics Inc. is a biopharmaceutical company. It engages in developing a new class of non-opioid analgesics. The company focuses on the development of Halneuron, IMC-1 and IMC-2. Dogwood Therapeutics Inc., formerly known as Virios Therapeutics Inc., is based in Alpharetta, GA.

See More

Key Turning Points

3rd Resistance Point 7.17
2nd Resistance Point 6.46
1st Resistance Point 5.96
Last Price 5.46
1st Support Level 4.75
2nd Support Level 4.04
3rd Support Level 3.54

See More

52-Week High 29.28
Fibonacci 61.8% 18.71
Fibonacci 50% 15.45
Fibonacci 38.2% 12.19
Last Price 5.46
52-Week Low 1.62

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro